Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed

The Food and Drug Administration is offering fiscal year 2024 funding through a cooperative agreement to support long-term data collection on antimicrobial use across multiple animal sectors, including domestic livestock, poultry, companion animals such as dogs, cats, and horses, and minor species like fish, sheep, and goats. The initiative aims to gather comprehensive, representative data to better understand patterns of antimicrobial consumption in veterinary settings and to contribute to the development of standardized data collection frameworks. This effort is part of broader national objectives to promote antimicrobial stewardship and aligns with the National Action Plan by engaging key stakeholders in animal health and agriculture to improve transparency and responsible use of antimicrobials. The project will function through a public-private partnership model, where the awardee is expected to provide both data and subject matter expertise to help shape future frameworks for monitoring antimicrobial use. The funding opportunity is explicitly not open for clinical trials and is structured as a U01 cooperative agreement, emphasizing collaboration and shared responsibility between the FDA and the recipient. Janelle Fundersburg of the FDA serves as the point of contact for grants management, and the opportunity was posted on November 29, 2023, under the Department of Health and Human Services. The work will directly support FDA’s mission to protect public health by reducing the risks associated with antimicrobial resistance in animal populations.